Xue Meng
Kunming Medical University(CN)Korea Pharma (South Korea)(KR)First Affiliated Hospital of Kunming Medical University(CN)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Histone Deacetylase Inhibitors Research, Radiomics and Machine Learning in Medical Imaging, Lung Cancer Diagnosis and Treatment, Medical Imaging Techniques and Applications
Most-Cited Works
- → Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer(2022)64 cited
- → Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non–small-cell lung cancer(2007)47 cited
- → Systemic Immune Activation and Responses of Irradiation to Different Metastatic Sites Combined With Immunotherapy in Advanced Non-Small Cell Lung Cancer(2021)37 cited
- → Early detection of radiation-induced heart disease using 99mTc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy(2015)32 cited
- → Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules(2019)26 cited